摘要
The rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented public health crisis worldwide. Recent studies indicate that a hyperinflammatory syndrome induced by SARS-CoV-2 contributes to disease severity and mortality in COVID-19. In this review, an overview of the pathophysiology underlying the hyperinflammatory syndrome in severe COVID-19 is provided. The current evidence suggests that the hyperinflammatory syndrome results from a dysregulated host innate immune response. The gross and microscopic pathologic findings as well as the alterations in the cytokine milieu, macrophages/monocytes, natural killer cells, T cells, and neutrophils in severe COVID-19 are summarized. The data highlighted include the potential therapeutic approaches undergoing investigation to modulate the immune response and abrogate lung injury in severe COVID-19.
- COVID-19: immunopathogenesis and Immunotherapeutics.Yang, Li; Liu, Shasha; Liu, Jinyan; Zhang, Zhixin; Wan, Xiaochun; Huang, Bo; Chen, Youhai; Zhang, Yi*Signal Transduct Target Ther, 2020, 5(1): 128.
- COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium InjuryWang, Zhongfang; Yang, Xiaoyun; Zhou, Yumin; Sun, Jing; Liu, Xiaoqing; Zhang, Jing; Mei, Xinyue; Zhong, Jiaying; Zhao, Jincun; Ran, Pixin*American Journal of Respiratory and Critical Care Medicine, 2020, 202(4): 606-+.被引 30
- Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 DeteriorationChen, Ruirong; Lan, Zhien; Ye, Jujian; Pang, Limin; Liu, Yi; Wu, Wei; Qin, Xiaohuan; Guo, Yang*; Zhang, Peidong*Frontiers in Immunology, 2021, 12: 589095.被引 92
